Every brand wants to make a good impression online, but having a standout website or social media presence isn’t enough. These days, everyone has an opinion on just about everything, and customers are ...

Orm Kornnaphat Sethratanapong, better known as Orm Kornnaphat, has been a name impossible to ignore in the past year—especially when it comes to big names in Thai entertainment or who’s been trending ...

Orum Therapeutics Inc. on April 26 pulled the plug on a U.S.-based phase I study of ORM-5029, its lead oncology degrader antibody conjugate (DAC) asset, a decision that came months after the company ...

Beyond Orm’s artistic talents, her family also runs Sethachon Co., Ltd, a prominent frozen foods manufacturer and exporter in Thailand. She completed her primary schooling at Wattana Wittaya Academy ...

Thai actresses Sirilak Kwong, aka Lingling, and Kornnaphat Sethratanapong, aka Orm, will be coming to Manila for their first fan meeting. Ling and Orm starred in the Thai GL (girls’ love) series “The ...

Vertex Pharmaceuticals will use Orum Therapeutics’ dual-precision targeted protein degradation (TPD² ®) technology platform to discover targeted conditioning agents for use with gene editing therapies ...

Need help choosing the best Python ORM for your projects? Here's what you need to know about SQLAlchemy, PonyORM, Django ORM, Peewee, SQLObject, and Tortoise ORM. When you want to work with a ...

BOSTON & DAEJEON, South Korea--(BUSINESS WIRE)--Orum Therapeutics (“Orum”), a clinical-stage private biotechnology company pioneering Dual-Precision Targeted Protein Degradation (TPD² ™) and Targeted ...

Another day, another antibody-drug conjugate deal. This time it’s Bristol Myers Squibb snapping up Orum Therapeutics’ phase 1 blood cancer med for $100 million upfront. Orum will also be eligible for ...